| Symbol | CDXS |
|---|---|
| Name | CODEXIS, INC. |
| Sector | INDUSTRIALS |
| Region | North America |
| Industry | Major Chemicals |
| Address | 200 PENOBSCOT DRIVE, REDWOOD CITY, California, 94063, United States |
| Telephone | +1 650 421-8100 |
| Fax | — |
| — | |
| Website | https://www.codexis.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001200375 |
| Description | Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver(R)technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis(TM) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Additional info from NASDAQ: |
New Form SCHEDULE 13G - CODEXIS, INC. <b>Filed:</b> 2026-07-29 <b>AccNo:</b> 0000898432-26-000560 <b>Size:</b> 1 MB
Read moreNew Form 424B5 - CODEXIS, INC. <b>Filed:</b> 2026-07-24 <b>AccNo:</b> 0001193125-26-316045 <b>Size:</b> 466 KB
Read moreNew Form 424B5 - CODEXIS, INC. <b>Filed:</b> 2026-07-23 <b>AccNo:</b> 0001193125-26-314241 <b>Size:</b> 468 KB
Read more